🔎 Trials Near Me

Hjem › Alzheimers sykdom › New York

Kliniske studier for Alzheimers sykdom i New York

37 studier for Alzheimers sykdom søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  • Clinical Site, New York
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT06887192

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 1656, New Windsor
  • Local Institution - 2619, Staten Island
  • Local Institution - 1658, Woodmere
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06937229

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

  • Alzheimer's Disease Research Center, Albany
RekruttererFase 4
Alder 50 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07633470

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Mid Hudson Medical Research PLLC, New Windsor
  • SUNY Upstate Medical University, Syracuse
  • Five Towns Neurology, PC, Woodmere
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06585787

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

  • Alzheimer's Disease Research Center, Albany
  • Adams Clinic Harlem, New York
RekruttererFase 2
Alder 55 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Basil Clinical, Laurelton
  • Weill Cornell Medical College, New York
  • Adams Clinical Harlem, New York
  • og 2 flere
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Neurological Associates Albany, Albany
  • Dent Neurosciences Research Center, Inc, Amherst
  • University at Buffalo - UBMD Neurology, Buffalo
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06976203

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • Local Institution - 1610, Inwood
  • Mid Hudson Medical Research, New Windsor
  • Five Towns Neurology PC -Woodmere - 923 Broadway, Woodmere
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • Local Institution - 2647, Brooklyn
  • Richmond Behavioral Associates, Staten Island
  • Walnut Clinical Research, Valley Stream
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

  • Basil Clinical, Laurelton
RekruttererFase 3
Alder 55 til 80 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT07717411

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • University at Buffalo - UBMD Neurology, Buffalo
  • The Feinstein Institute for Medical Research, Manhasset
  • Mid Hudson Medical Research, New Windsor
  • og 1 flere
RekruttererFase 2
Alder 55 til 90 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • Alzheimer Disease Research Center (ADRC) ( Site 1000), Albany
  • Mid Hudson Medical Research ( Site 1050), New Windsor
  • Basil Clinical ( Site 1065), Queens
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07033494

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

  • The Research Foundation for State University of New York, Buffalo
Rekrutterer
Alder 50 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT07178210

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • NYU Langone Health, New York
  • SUNY Upstate Medical University, Syracuse
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06976216

Early Age-Related Hearing Loss Investigation (EARHLI)

  • Columbia University Medical Center, New York
Rekrutterer
Alder 55 til 75 · Alle kjønn · Oppdatert 12. aug. 2026 · NCT06174038

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

  • New York University, New York
  • Mount Sinai, New York
Rekrutterer
Alder 55 til 85 · Alle kjønn · Oppdatert 6. aug. 2026 · NCT05988385

Autoimmune Features of Neurodegenerative Disorders

  • Columbia University Medical Center, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 55 til 90 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT04239079

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • New York University (NYU) School of Medicine - Langone Medical Center, New York
  • Mount Sinai Hospital, New York
  • Columbia University Medical Center, New York
  • og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • New York University Medical Center, New York
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05552157

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

  • New York University Medical Center, New York
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT06647498

Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia

  • NYU Rory Meyers College of Nursing and VNS Health, New York
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jul. 2026 · NCT07182357

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

  • Columbia University Irving Medical Center, New York
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
Alder 50 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04576793

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

  • Weill Cornell Medicine Brain Health Imaging Institute, New York
RekruttererFase 2
Alder 50 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT07553338

[18F]PI-2620 Phase 3 Histopathological Study

  • Velocity Clinical Research, East Syracuse
  • Ichor Research, Syracuse
RekruttererFase 3
Alder 50 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT05641688

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS Only, Staten Island
RekruttererObservasjonsstudie
Alder 25 til 55 · Alle kjønn · Oppdatert 18. mai 2026 · NCT04165109

Late Onset Alzheimer's Disease

  • Columbia University Irving Medical Center, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 55 og eldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT05010603

Tele-Savvy for Latino Caregivers

  • University of Rochester School of Nursing, Rochester
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 14. mai 2026 · NCT07290387

Aβ Dynamics in LLMD

  • NYU Langone Health, New York
  • Nathan S. Kline Institute for Psychiatric Research, Orangeburg
RekruttererFase 4
Alder 60 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT05004987

Genetic Studies of Early-onset Dementia

  • Columbia University Irving Medical Center, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 35 og eldre · Alle kjønn · Oppdatert 29. apr. 2026 · NCT04906863

Tau Networks in Psychotic Alzheimer's Disease

  • The Feinstein Institutes for Medical Research, Manhasset
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 65 til 85 · Alle kjønn · Oppdatert 8. apr. 2026 · NCT05847192

Dementia Caregivers' Link to Assistance and Resources

  • VNS Health Home Care, New York
RekruttererFrivillige helsepersonell ønskes velkommen
Alle aldre · Alle kjønn · Oppdatert 13. mar. 2026 · NCT06860035

Evaluating the Efficacy of the Pain Identification and Communication Toolkit

  • Weill Cornell Medicine, New York
Rekrutterer
Alder 21 og eldre · Alle kjønn · Oppdatert 12. feb. 2026 · NCT06168604

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Staten Island
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 2. feb. 2026 · NCT07105709

Daridorexant to Prevent Post-cardiotomy Delirium

  • University of Rochester Medical Center, Rochester
RekruttererFase 2
Alder 60 og eldre · Alle kjønn · Oppdatert 7. jan. 2026 · NCT07217912

Innate Immunity Stimulation Via TLR9 in Early AD

  • NYU Langone Health, New York
RekruttererFase 1
Alder 60 til 85 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT05606341

NYSCF Scientific Discovery Biobank

  • New York Stem Cell Foundation Research Institute, New York
RekruttererObservasjonsstudie
30 Days · Alle kjønn · Oppdatert 3. mar. 2025 · NCT06203106

Triage Survey for Neurology Research Eligibility

  • Berman Clinical, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. okt. 2023 · NCT06104852

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.